External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

ASGCT 2024

May 07 - May 11

Baltimore, USA

asgct.org

We will be contributing to topics related to

Neuroscience

Add to calendar

Agenda

Medical Materials

04:00 PM

90mins Baltimore, USA

Immunologic investigations into transgene-directed immune-mediated myositis following delandistrogene moxeparvovec▼ gene therapy

Sohrab Khan, Helene Haegel, Andres Hollenstein,Christoph Wandel, Damon Asher, Danielle Griffin, Emanuel Palatinsky, Stefanie Mason, Rachael Potter, Ida Moeller, Susan Iannaccone, Craig Zaidman, Louise Rodino-Klapac

Neuroscience | Duchenne Muscular Dystrophy

Notify me

Add to calendar

04:00 PM

90mins Baltimore, USA

Safety and Efficacy of Delandistrogene Moxeparvovec▼ Versus Placebo in Duchenne Muscular Dystrophy: Phase 3 EMBARK Primary Results

Jerry R. Mendell, Francesco Muntoni, Craig M. McDonald, Eugenio M. Mercuri, Emma Ciafaloni, Hirofumi Komaki, Carmen Leon-Astudillo, Andrés Nascimento, Crystal Proud, Ulrike Schara-Schmidt, Aravindhan Veerapandiyan, Craig M. Zaidman, Maitea Guridi, Alexander P. Murphy, Carol Reid, Christoph Wandel, Damon R. Asher, Eddie Darton, Stefanie Mason, Rachael A. Potter, Teji Singh, Wenfei Zhang, Paulo Fontoura, Jacob S. Elkins, Louise R. Rodino-Klapac

Neuroscience | Duchenne Muscular Dystrophy

Notify me

Add to calendar

Coming soon

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.